Treatment(s) now being considered-Immunotherapy Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Immunotherapy Posts on Medivizor

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Evaluating immune-related side effets in patients with advanced melanoma treated with immunotherapies

Posted by on Jun 28, 2020 in Melanoma | 0 comments

In a nutshell The study monitored the occurrence of possible immune-related side effects (irSEs) in patients with advanced melanoma under single and combination therapy of ipilimumab (I; Yervoy), nivolumab (N; Opdivo), and pembrolizumab (P; Keytruda). The authors found that combination therapy increases the frequency of irSEs. Some background...

Read More

What gut-related side effects do immunotherapy drugs and chemotherapy cause patients with cancer?

Posted by on Apr 14, 2020 in Breast cancer | 0 comments

In a nutshell This study examined if certain immunotherapy drugs increased the risk of developing side effects in the gut in patients with cancer also receiving chemotherapy. The results showed that immunotherapy drugs increased the risks of developing gut-related side effects compared to chemotherapy alone. Some background Immunotherapy drugs that...

Read More

What gut-related side effects do immunotherapy drugs and chemotherapy cause patients with cancer?

Posted by on Apr 14, 2020 in Melanoma | 0 comments

In a nutshell This study examined if certain immunotherapy drugs increased the risk of developing side effects in the gut in patients with cancer also receiving chemotherapy. The results showed that immunotherapy drugs increased the risks of developing gut-related side effects compared to chemotherapy alone. Some background...

Read More

What types of skin-related side effects do biological treatments cause in patients with melanoma?

Posted by on Apr 3, 2020 in Melanoma | 0 comments

In a nutshell This article reviewed the types and frequency of different skin-related side effects that patients with melanoma experience while receiving biological treatments. Some background Treatment for patients with melanoma has changed in recent years from chemotherapy to biological therapies. Biological therapies include BRAF inhibitors...

Read More

Association of side effects and response to treatment in patients with melanoma treated with nivolumab

Posted by on Dec 27, 2018 in Melanoma | 0 comments

In a nutshell This study wanted to find out if patients with melanoma who had immune system side effects after treatment with nivolumab (Opdivo) had better outcomes than patients without side effects. The study found that the patients who had side effects from using nivolumab ended up with better responses to treatment and...

Read More

What factors can predict if melanoma patients respond to anti-PD-1 immunotherapy?

Posted by on Aug 2, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether there was a relationship between specific tumor characteristics (biomarkers) in melanoma patients and response to anti-PD-1 immunotherapy. This study found that patients with certain tumor characteristics had a better response to anti-PD-1 immunotherapy and experienced increased survival. Some background...

Read More

Treatment with vemurafenib plus cobimetinib does not affect health related quality of life in advanced melanoma patients

Posted by on Apr 1, 2018 in Melanoma | 0 comments

In a nutshell This study examined the side effects and health related quality of life (HRQL) of advanced melanoma patients treated with cobimetinib (Cotellic) plus vemurafenib (Zelboraf). Researchers suggested that these patients maintained their HRQL when compared with patients treated with vemurafenib alone. Some background Prior studies...

Read More

A review in melanoma brain metastasis treatment

Posted by on Nov 18, 2017 in Melanoma | 0 comments

In a nutshell This study reviewed the currently available treatments for melanoma brain metastasis (MBM; spread to the brain). Researchers reported that treatment should be personalized for the different types of patients.  Some background Melanoma has the highest risk of spreading to the brain among all common cancer types. Until the last...

Read More

Side effects of targeted therapies to treat metastatic colorectal cancer

Posted by on Nov 18, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the negative side effects of targeted therapy to treat elderly and younger metastatic (spread to other parts of the body) colorectal cancer patients. Researchers suggested that side effects were different between these patients. Some background Colorectal cancer is one of the most common cancers worldwide....

Read More